%0 Journal Article
%A Váraljai, Renáta
%A Zimmer, Lisa
%A Al-Matary, Yahya
%A Kaptein, Paulien
%A Albrecht, Lea J
%A Shannan, Batool
%A Brase, Jan C
%A Gusenleitner, Daniel
%A Amaral, Teresa
%A Wyss, Nina
%A Utikal, Jochen
%A Flatz, Lukas
%A Rambow, Florian
%A Reinhardt, Hans Christian
%A Dick, Jenny
%A Engel, Daniel R
%A Horn, Susanne
%A Ugurel, Selma
%A Sondermann, Wiebke
%A Livingstone, Elisabeth
%A Sucker, Antje
%A Paschen, Annette
%A Zhao, Fang
%A Placke, Jan M
%A Klose, Jasmin M
%A Fendler, Wolfgang P
%A Thommen, Daniela S
%A Helfrich, Iris
%A Schadendorf, Dirk
%A Roesch, Alexander
%T Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
%J Nature cancer
%V 4
%N 9
%@ 2662-1347
%C London
%I Nature Research
%M DKFZ-2023-01651
%P 1395
%D 2023
%Z 2023 Sep;4(9):1395
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37580519
%R 10.1038/s43018-023-00632-w
%U https://inrepo02.dkfz.de/record/278417